Perioperative intensive insulin therapy using artificial endocrine pancreas in patients undergoing pancreatectomy

World Journal of Gastroenterology

Volumn 15, Issue 33, 2009, Pages 4111-4115

  Maeda, Hiromichi ^a   Okabayashi, Takehiro ^a   Yatabe, Tomoaki ^a   Yamashita, Koichi ^a   Hanazaki, Kazuhiro ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Artificial; Blood glucose; Diabetes mellitus; Hyperglycemia; Pancreas; Pancreatectomy

Indexed keywords

GLUCAGON; INSULIN; PANCREAS POLYPEPTIDE;

ACCURACY; ARTIFICIAL PANCREAS; BLOOD GLUCOSE MONITORING; EXPERIMENTAL STUDY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HORMONAL REGULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; NONHUMAN; PANCREAS RESECTION; PANCREATOGENIC DIABETES; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; RELIABILITY; REVIEW; ANIMAL; DOG; HYPERGLYCEMIA; INSULIN INFUSION; PHYSIOLOGY;

ANIMALS; BLOOD GLUCOSE; DOGS; GLUCAGON; HUMANS; HYPERGLYCEMIA; INSULIN INFUSION SYSTEMS; PANCREATECTOMY; PANCREATIC POLYPEPTIDE; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS;

EID: 70449722983     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.4111     Document Type: Review

References (38)

1. Klover PJ, Mooney RA. Hepatocytes: critical for glucose homeostasis. Int J Biochem Cell Biol 2004; 36: 753-758
2. Herman MA, Kahn BB. Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J Clin Invest 2006; 116: 1767-1775
3. Sacca L, Vigorito C, Cicala M, Corso G, Sherwin RS. Role of gluconeogenesis in epinephrine-stimulated hepatic glucose production in humans. Am J Physiol 1983; 245: E294-E302
4. Ganda OP. Secondary forms of diabetes. In: Kahn CR, Weir GC, editors. Joslin's diabetes mellitus. 13th ed. Malvern, PA: Lea & Febiger, 1994: 300-316
5. King J, Kazanjian K, Matsumoto J, Reber HA, Yeh MW, Hines OJ, Eibl G. Distal pancreatectomy: incidence of postoperative diabetes. J Gastrointest Surg 2008; 12: 1548-1553
6. Lillemoe KD, Kaushal S, Cameron JL, Sohn TA, Pitt HA, Yeo CJ. Distal pancreatectomy: indications and outcomes in 235 patients. Ann Surg 1999; 229: 693-698; discussion 698-700
7. Hutchins RR, Hart RS, Pacifico M, Bradley NJ, Williamson RC. Long-term results of distal pancreatectomy for chronic pancreatitis in 90 patients. Ann Surg 2002; 236: 612-618
8. Slezak LA, Andersen DK. Pancreatic resection: effects on glucose metabolism. World J Surg 2001; 25: 452-460
9. Nosadini R, del Prato S, Tiengo A, Duner E, Toffolo G, Cobelli C, Faronato PP, Moghetti P, Muggeo M. Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes. Diabetes 1982; 31: 346-355
10. Fisher WE, Andersen DK, Bell RH, Saluja AK, Brunicardi FC. Pancreas. In: Brunicardi FC, editor. Schwartz's principles of surgery. 8th ed. New York: McGraw-Hill, 2005: 1252-1254
11. Seymour NE, Brunicardi FC, Chaiken RL, Lebovitz HE, Chance RE, Gingerich RL, Elahi D, Andersen DK. Reversal of abnormal glucose production after pancreatic resection by pancreatic polypeptide administration in man. Surgery 1988; 104: 119-129
12. Heidt DG, Burant C, Simeone DM. Total pancreatectomy: indications, operative technique, and postoperative sequelae. J Gastrointest Surg 2007; 11: 209-216
13. Cunningham JD, O'Donnell N, Starker P. Surgical outcomes following pancreatic resection at a low-volume community hospital: do all patients need to be sent to a regional cancer center? Am J Surg 2009; 198: 227-230
14. Helm JF, Centeno BA, Coppola D, Druta M, Park JY, Chen DT, Hodul PJ, Kvols LK, Yeatman TJ, Carey LC, Karl RC, Malafa MP. Outcomes following resection of pancreatic adenocarcinoma: 20-year experience at a single institution. Cancer Control 2008; 15: 288-294
15. Albacker T, Carvalho G, Schricker T, Lachapelle K. Highdose insulin therapy attenuates systemic inflammatory response in coronary artery bypass grafting patients. Ann Thorac Surg 2008; 86: 20-27
16. Hagiwara S, Iwasaka H, Hasegawa A, Koga H, Noguchi T. Effects of hyperglycemia and insulin therapy on high mobility group box 1 in endotoxin-induced acute lung injury in a rat model. Crit Care Med 2008; 36: 2407-2413
17. Unger RH. Glucagon physiology and pathophysiology. N Engl J Med 1971; 285: 443-449
18. Sun YS, Brunicardi FC, Druck P, Walfisch S, Berlin SA, Chance RE, Gingerich RL, Elahi D, Andersen DK. Reversal of abnormal glucose metabolism in chronic pancreatitis by administration of pancreatic polypeptide. Am J Surg 1986; 151: 130-140
19. Malaisse-Lagae F, Stefan Y, Cox J, Perrelet A, Orci L. Identification of a lobe in the adult human pancreas rich in pancreatic polypeptide. Diabetologia 1979; 17: 361-365
20. Baetens D, Malaisse-Lagae F, Perrelet A, Orci L. Endocrine pancreas: three-dimensional reconstruction shows two types of islets of langerhans. Science 1979; 206: 1323-1325
21. Andersen DK. The role of pancreatic polypeptide in glucose metabolism. In: Thompson JC, editor. Gastrointestinal endocrinology: receptors and post-receptor mechanisms. San Diego: Academic Press, 1990: 333
22. Kono T, Hanazaki K, Yazawa K, Ashizawa S, Fisher WE, Wang XP, Nosé Y, Brunicardi FC. Pancreatic polypeptide administration reduces insulin requirements of artificial pancreas in pancreatectomized dogs. Artif Organs 2005; 29: 83-87
23. Shilling AM, Raphael J. Diabetes, hyperglycemia, and infections. Best Pract Res Clin Anaesthesiol 2008; 22: 519-535
24. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 1999; 22: 1408-1414
25. Olsen MA, Nepple JJ, Riew KD, Lenke LG, Bridwell KH, Mayfield J, Fraser VJ. Risk factors for surgical site infection following orthopaedic spinal operations. J Bone Joint Surg Am 2008; 90: 62-69
26. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367
27. Pomposelli JJ, Baxter JK 3rd, Babineau TJ, Pomfret EA, Driscoll DF, Forse RA, Bistrian BR. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 1998; 22: 77-81
28. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008; 300: 933-944
29. Lacherade JC, Jabre P, Bastuji-Garin S, Grimaldi D, Fangio P, Theron V, Outin H, De Jonghe B. Failure to achieve glycemic control despite intensive insulin therapy in a medical ICU: incidence and influence on ICU mortality. Intensive Care Med 2007; 33: 814-821
30. Yamashita K, Okabayashi T, Yokoyama T, Yatabe T, Maeda H, Manabe M, Hanazaki K. The accuracy of a continuous blood glucose monitor during surgery. Anesth Analg 2008; 106: 160-163, table of contents
31. Yamashita K, Okabayashi T, Yokoyama T, Yatabe T, Maeda H, Manabe M, Hanazaki K. Accuracy and reliability of continuous blood glucose monitor in post-surgical patients. Acta Anaesthesiol Scand 2009; 53: 66-71
32. Okabayashi T, Hnazaki K, Nishimori I, Sugimoto T, Maeda H, Yatabe T, Dabanaka K, Kobayashi M, Yamashita K. Continuous post-operative blood glucose monitoring and control using a closed-loop system in patients undergoing hepatic resection. Dig Dis Sci 2008; 53: 1405-1410
33. Okabayashi T, Nishimori I, Maeda H, Yamashita K, Yatabe T, Hanazaki K. Effect of intensive insulin therapy using a closed-loop glycemic control system in hepatic resection patients: a prospective randomized clinical trial. Diabetes Care 2009; 32: 1425-1427
34. Hanazaki K, Nosé Y, Brunicardi FC. Artificial endocrine pancreas. J Am Coll Surg 2001; 193: 310-322
35. Matthews DE, Battezzati A. Regulation of protein metabolism during stress. Curr Opin Gen Surg 1993; 72-77
36. Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Maeda H, Yatabe T, Kohsaki T, Kobayashi M, Hanazaki K. Continuous postoperative blood glucose monitoring and control by an artificial pancreas in patients undergoing pancreatic resection: a prospective randomized clinical trial. Arch Surg 2009; In press
37. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297
38. Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICESUGAR study data. CMAJ 2009; 180: 821-827